Securing Leadership in Biotechnology & Advanced Biomanufacturing
The Advanced Regenerative Manufacturing Institute (ARMI) is a Department of Defense-sponsored Manufacturing Innovation Institute, advancing the U.S. bioeconomy by enabling scalable, secure, and cost-effective production of regenerative medicine technologies. Through its program BioFabUSA, ARMI is accelerating the development of critical biotechnologies and building a domestic ecosystem for advanced biomanufacturing that supports national security, health resilience, and economic growth.
BiofabUSA
BioFabUSA, a public-private partnership with more than 170 members across industry, academia, and government, is driving technical and strategic leadership in the development and manufacturing of cell, tissue, and organ-based products. The institute’s work strengthens domestic supply chains, supports dual-use technology development, and prepares a skilled workforce to meet the demands of a growing, globally competitive bioeconomy.
ARMI BioIndustries
ARMI BioIndustries is the development, manufacturing, and commercialization arm of the Advanced Regenerative Manufacturing Institute (ARMI). It provides full-service support to advance regenerative medicine technologies from concept to production—offering the infrastructure, expertise, and capabilities needed to bring innovative biomanufacturing solutions to market.
NextFab
NextFab is the first Foundry for American Biotechnology, established to strengthen the nation’s health security and accelerate biotechnology innovation. Its mission is to support the development of technologies that help the United States prepare for and respond to health-related threats, improve everyday medical care, and expand domestic capacity for advanced biomanufacturing.
BioFabUSA Membership
As an ARMI | BioFabUSA member, your organization becomes part of a national network driving the future of regenerative medicine and advanced manufacturing.
Members benefit from the collective expertise and capabilities of partners across industry, academia, government, and nonprofits. Together, we are building the technologies, standards, and workforce needed to transition tissue engineering and regenerative medicine from research to scalable, commercially viable solutions.
Membership provides opportunities to collaborate, access shared resources, and stay at the forefront of innovation in a field critical to U.S. health, economic, and national security priorities.
News
ReGen Valley: ‘The future of our country — really, the future of humanity — is being written right here in the Millyard’
ARMI and community leaders marked a major milestone with the groundbreaking of the biomanufacturing facility and training center—expanding America’s biomanufacturing capacity and shaping the future of regenerative medicine.
Events
-
Rockwell Automation Fair 2025
McCormick Place Convention Center 2317 S. Indiana Ave., Chicago, IL, United StatesARMI sponsors Rockwell Automation Fair 2025 to explore smart manufacturing technologies and digital transformation in biomanufacturing and regenerative medicine.
-
Careers of Tomorrow – Museum of Science, Boston
Museum of Science 1 Science Pk, Boston, MA, United StatesThe ARMI Education & Workforce Development (EWD) team will participate in the Careers of Tomorrow event at the Museum of Science in Boston on Saturday, December 6, 2025, from 9:00
-
Advanced Therapies Week 2026
San Diego Convention Center & Hilton San Diego Bayfront 1 Park Boulevard,, San Diego, CA, United StatesARMI | BioFabUSA is partnering with Phacilitate for Advanced Therapies Week 2026 in San Diego — connecting members with global leaders in cell and gene therapy manufacturing. Members can reach out to their Account Manager for an exclusive registration discount.
-
Defense Manufacturing Conference (DMC) 2026
Caribe Royale Orlando 8101 World Center Drive, Orlando, FL, United StatesBioFabUSA will exhibit and present at DMC 2026, sharing how scalable biomanufacturing can strengthen U.S. defense capabilities and support resilient manufacturing systems.
“There are hurdles that need to be overcome with tissue and organs for human transplant, and sometimes the traditional connection between industry and academia can be slow going. ARMI | BioFabUSA can accelerate this.”
David Brafman
Associate Professor at Arizona State University
